Current aspects of pulmonary arterial hypertension and therapeutics

被引：0
|
作者：
Li, Xianchi [1 ]
Liu, Yuanyuang [1 ]
Zhang, Peiying [1 ]
机构：
[1] Xuzhou Cent Hosp, Xuzhou, Peoples R China
来源：
MINERVA CARDIOANGIOLOGICA | 2017年 / 65卷 / 02期
关键词：
Hypertension; pulmonary; Therapeutics; Adrenergic beta-antagonists; RIGHT-VENTRICULAR FUNCTION; CALCIUM-CHANNEL BLOCKERS; LONG-TERM RESPONSE; SIGNALING CONTRIBUTES; AEROBIC EXERCISE; SURVIVAL; PROSTACYCLIN; MANAGEMENT; PHYSIOLOGY; DISEASE;
D O I：
10.23736/S0026-4725.16.04266-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The pulmonary arterial hypertension (PAH) patients have high rate of mortality due to right ventricle (or ventricular) (RV) failures. A lot of research work is being carried out in the area, however no treatment is available that could contrast the rise in mortality rates in PAH patients. beta 1-adrenoceptor blockers (beta-blockers, BB) reduced mortality in left heart failure, but they do not explored much at clinical level. Recent studies suggest beta-blockers might be beneficial in PAH; however the mechanisms remain unknown. The present review article would put light on all these aspects of PAH along with latest ways for the management of PAH.
引用
收藏
页码：173 / 178
页数：6
相关论文
共 50 条
  • [31] Titration of pulmonary arterial hypertension therapeutics: Experience-based recommendations
    Lombardi, Sandra
    Kingman, Martha
    Duncan, Maribeth
    Berngard, Samuel Clark
    Fernandes, Timothy
    RESPIRATORY MEDICINE, 2018, 143 : 139 - 146
  • [32] Hemodynamics in Pulmonary Arterial Hypertension: Current and Future Perspectives
    Saggar, Rajan
    Sitbon, Olivier
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 9S - 15S
  • [33] Current and Future Therapeutic Targets for Pulmonary Arterial Hypertension
    Fraidenburg, Dustin
    Yuan, Jason
    HIGH ALTITUDE MEDICINE & BIOLOGY, 2013, 14 (02) : 134 - 143
  • [34] CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Andeev, S. N.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (04) : 57 - 63
  • [35] Clinical presentation and current classification of pulmonary arterial hypertension
    Bortman, Guillermo
    INSUFICIENCIA CARDIACA, 2009, 4 (01) : 27 - 32
  • [36] Genetics of pulmonary arterial hypertension: Current and future implications
    Elliott, CG
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (04) : 365 - 371
  • [37] Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
    Coons, James C.
    Empey, Philip
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2023, 16 : 729 - 737
  • [38] Current and advancing treatments for pulmonary arterial hypertension in childhood
    Zijlstra, Willemijn M. H.
    Ploegstra, Mark-Jan
    Berger, Rolf M. F.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (05) : 615 - 628
  • [39] Immunopathological aspects of schistosomiasis-associated pulmonary arterial hypertension
    Mauad, Thais
    Pozzan, Geanette
    Lancas, Tatiana
    Overbeek, Maria J.
    Souza, Rogerio
    Jardim, Carlos
    Dolhnikoff, Marisa
    Mello, George
    Pires-Neto, Ruy Camargo
    Bernardi, Fabiola del Carlo
    Grunberg, Katrien
    JOURNAL OF INFECTION, 2014, 68 (01) : 90 - 98
  • [40] Nitrate-Nitrite-Nitric Oxide Pathway in Pulmonary Arterial Hypertension Therapeutics
    Sparacino-Watkins, Courtney E.
    Lai, Yen-Chun
    Gladwin, Mark T.
    CIRCULATION, 2012, 125 (23) : 2824 - 2826
12345